Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Leukemia

Free Subscription Articles published in Br J Haematol Retrieve available abstracts of 172 articles: HTML format Text format

Single Articles

October 2009
1. SMITH AR , Wagner JE
   Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood.
   Br J Haematol. 2009;147:246-61.
   PubMed     Text format     Related articles    Abstract available
   
   
   September 2009
2. NOREN-NYSTROM U , Heyman M, Frisk P, Golovleva I, et al
   Vascular density in childhood acute lymphoblastic leukaemia correlates to biological factors and outcome.
   Br J Haematol. 2009;146:521-30.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. COSTA LJ
   Impact of allogeneic haematopoietic stem cell transplantation in the outcome of Ph+ acute lymphoblastic leukaemia treated with an imatinib-containing regimen.
   Br J Haematol. 2009;146:576-7.
   PubMed     Text format     Related articles   
   
   
   August 2009
4. LIANG XS , Caporaso N, McMaster ML, Ng D, et al
   Common genetic variants in candidate genes and risk of familial lymphoid malignancies.
   Br J Haematol. 2009;146:418-23.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. PATEL H , Gordon MY
   Abnormal centrosome-centriole cycle in chronic myeloid leukaemia?
   Br J Haematol. 2009;146:408-17.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. BOSANQUET AG , Richards SM, Wade R, Else M, et al
   Drug cross-resistance and therapy-induced resistance in chronic lymphocytic leukaemia by an enhanced method of individualised tumour response testing.
   Br J Haematol. 2009;146:384-95.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. MITCHELL C , Payne J, Wade R, Vora A, et al
   The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99.
   Br J Haematol. 2009;146:424-36.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. STUSSI G , Tichelli A, Schanz U, Goede J, et al
   Hypereosinophilia with a low blast count as the initial manifestation of acute myeloid leukaemia with RUNX1-RUNX1T1.
   Br J Haematol. 2009;146:346.
   PubMed     Text format     Related articles   
   
   
   
9. WONG KF , Siu LL, Wong WS
   Aleukaemic acute myeloid leukaemia with t(8;21)(q22;q22).
   Br J Haematol. 2009;146:345.
   PubMed     Text format     Related articles   
   
   
   
10. SIBSON K , Steward C, Moppett J, Cornish J, et al
    Dismal long-term prognosis for children with refractory acute myeloid leukaemia treated with gemtuzumab ozogamicin and stem cell transplantation: where now?
    Br J Haematol. 2009;146:342-4.
    PubMed     Text format     Related articles   
    
    
    
11. AMMATUNA E , Cavaliere A, Divona M, Amadori S, et al
    Successful pregnancy after arsenic trioxide therapy for relapsed acute promyelocytic leukaemia.
    Br J Haematol. 2009;146:341.
    PubMed     Text format     Related articles   
    
    
    
12. MAHINDRA A , Bolwell B, Sobecks R, Rybicki L, et al
    Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation.
    Br J Haematol. 2009;146:310-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. SUTTON R , Venn NC, Tolisano J, Bahar AY, et al
    Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia.
    Br J Haematol. 2009;146:292-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. PAYNE E , Look T
    Zebrafish modelling of leukaemias.
    Br J Haematol. 2009;146:247-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. WAMPFLER J , Tschan MP, Shan D, Laemmle A, et al
    SIRT1 is downregulated during neutrophil differentiation of acute promyelocytic leukaemia cells.
    Br J Haematol. 2009;146:337-41.
    PubMed     Text format     Related articles   
    
    
    June 2009
16. DECKER M , Went P
    Placental barrier in acute myeloid leukemia.
    Br J Haematol. 2009;145:553.
    PubMed     Text format     Related articles   
    
    
    
17. GARNACHE-OTTOU F , Feuillard J, Ferrand C, Biichle S, et al
    Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia.
    Br J Haematol. 2009;145:624-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. GRUBER F , Mustjoki S, Porkka K
    Impact of tyrosine kinase inhibitors on patient outcomes in Philadelphia chromosome-positive acute lymphoblastic leukaemia.
    Br J Haematol. 2009;145:581-97.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. WHEATLEY K , Brookes CL, Howman AJ, Goldstone AH, et al
    Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trials.
    Br J Haematol. 2009;145:598-605.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. JI M , Li J, Yu H, Ma D, et al
    Simultaneous targeting of MCL1 and ABCB1 as a novel strategy to overcome drug resistance in human leukaemia.
    Br J Haematol. 2009;145:648-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. BRUNETTI L , Di Noto R, Abate G, Gorrese M, et al
    CD200/OX2, a cell surface molecule with immuno-regulatory function, is consistently expressed on hairy cell leukaemia neoplastic cells.
    Br J Haematol. 2009;145:665-7.
    PubMed     Text format     Related articles   
    
    
    
22. BONNEY D , Razali H, Turner A, Will A, et al
    Successful treatment of human metapneumovirus pneumonia using combination therapy with intravenous ribavirin and immune globulin.
    Br J Haematol. 2009;145:667-9.
    PubMed     Text format     Related articles   
    
    
    
23. BACHER U , Kohlmann A, Haferlach T
    Current status of gene expression profiling in the diagnosis and management of acute leukaemia.
    Br J Haematol. 2009;145:555-68.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. TEACHEY DT , Grupp SA, Brown VI
    Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies.
    Br J Haematol. 2009;145:569-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. KOBAYASHI K , Yokote T, Nakayama S, Takubo T, et al
    Inappropriate antidiuretic hormone production by leukaemic blasts in acute myeloid leukaemia.
    Br J Haematol. 2009;145:554.
    PubMed     Text format     Related articles   
    
    
    
26. MORABITO F , Cutrona G, Gentile M, Matis S, et al
    Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia.
    Br J Haematol. 2009;146:44-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. ROSSI D , Sozzi E, Puma A, De Paoli L, et al
    The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors.
    Br J Haematol. 2009;146:64-75.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. WHEATLEY K , Goldstone AH, Littlewood T, Hunter A, et al
    Randomized placebo-controlled trial of granulocyte colony stimulating factor (G-CSF) as supportive care after induction chemotherapy in adult patients with acute myeloid leukaemia: a study of the United Kingdom Medical Research Council Adult Leukaemia Wo
    Br J Haematol. 2009;146:54-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. STORRING JM , Minden MD, Kao S, Gupta V, et al
    Treatment of adults with BCR-ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen.
    Br J Haematol. 2009;146:76-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. TORRES LA , Barbarroja N, Dorado G, Velasco F, et al
    VEGF/KDR loop is a target of AG1296 in acute myeloid leukaemia showing FLT3-internal tandem duplications.
    Br J Haematol. 2009;145:836-8.
    PubMed     Text format     Related articles   
    
    
    
31. GELSI-BOYER V , Trouplin V, Adelaide J, Bonansea J, et al
    Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia.
    Br J Haematol. 2009;145:788-800.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. DELGADO J , Pratt G, Phillips N, Briones J, et al
    Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate.
    Br J Haematol. 2009;145:801-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. INGRAM W , Chan L, Guven H, Darling D, et al
    Human CD80/IL2 lentivirus-transduced acute myeloid leukaemia (AML) cells promote natural killer (NK) cell activation and cytolytic activity: implications for a phase I clinical study.
    Br J Haematol. 2009;145:749-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. OLSNES AM , Ersvaer E, Ryningen A, Paulsen K, et al
    The protein kinase C agonist PEP005 increases NF-kappaB expression, induces differentiation and increases constitutive chemokine release by primary acute myeloid leukaemia cells.
    Br J Haematol. 2009;145:761-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. SUEMORI K , Fujiwara H, Ochi T, Azuma T, et al
    Identification of a novel epitope derived from CML66 that is recognized by anti-leukaemia cytotoxic T lymphocytes.
    Br J Haematol. 2009;146:115-8.
    PubMed     Text format     Related articles   
    
    
    
36. ELSE M , Dearden CE, Matutes E, Garcia-Talavera J, et al
    Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis.
    Br J Haematol. 2009;145:733-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. LUNDIN C , Davidsson J, Hjorth L, Behrendtz M, et al
    Tiling resolution array-based comparative genomic hybridisation analyses of acute lymphoblastic leukaemias in children with Down syndrome reveal recurrent gain of 8q and deletions of 7p and 9p.
    Br J Haematol. 2009;146:113-5.
    PubMed     Text format     Related articles   
    
    
    May 2009
38. MARIN D , Khorashad JS, Foroni L, Milojkovic D, et al
    Does a rise in the BCR-ABL1 transcript level identify chronic phase CML patients responding to imatinib who have a high risk of cytogenetic relapse?
    Br J Haematol. 2009;145:373-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. BURNETT AK , Milligan D, Goldstone A, Prentice A, et al
    The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial.
    Br J Haematol. 2009;145:318-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. SOUWER Y , Chamuleau ME, van de Loosdrecht AA, Tolosa E, et al
    Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
    Br J Haematol. 2009;145:334-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. SAULLE E , Riccioni R, Coppola S, Parolini I, et al
    Colocalization of the VEGF-R2 and the common IL-3/GM-CSF receptor beta chain to lipid rafts leads to enhanced p38 activation.
    Br J Haematol. 2009;145:399-411.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. 
    Beneficial and harmful effects of anthracyclines in the treatment of childhood acute lymphoblastic leukaemia: a systematic review and meta-analysis.
    Br J Haematol. 2009;145:376-88.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. BUNCE C
    Where now in elderly AML?
    Br J Haematol. 2009;145:333.
    PubMed     Text format     Related articles   
    
    
    
44. HUBACEK P , Virgili A, Ward KN, Pohlreich D, et al
    HHV-6 DNA throughout the tissues of two stem cell transplant patients with chromosomally integrated HHV-6 and fatal CMV pneumonitis.
    Br J Haematol. 2009;145:394-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. DI IASIO MG , Secchiero P, Tiribelli M, Zauli G, et al
    Reduced expression of cell cycle-associated genes in B lymphocytes purified from the peripheral blood of early-stage B chronic lymphocytic leukaemia patients.
    Br J Haematol. 2009;145:424-6.
    PubMed     Text format     Related articles   
    
    
    
46. GALLIPOLI P , Tang A, Leach M
    Cortical blindness due to sagittal sinus thrombosis in acute lymphoblastic leukaemia.
    Br J Haematol. 2009;145:270.
    PubMed     Text format     Related articles   
    
    
    
47. JUAREZ JG , Thien M, Dela Pena A, Baraz R, et al
    CXCR4 mediates the homing of B cell progenitor acute lymphoblastic leukaemia cells to the bone marrow via activation of p38MAPK.
    Br J Haematol. 2009;145:491-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. WITTEKINDT B , Berger A, Porto L, Vlaho S, et al
    Human herpes virus-6 DNA in cerebrospinal fluid of children undergoing therapy for acute leukaemia.
    Br J Haematol. 2009;145:542-5.
    PubMed     Text format     Related articles   
    
    
    
49. FULDA S
    Therapeutic opportunities for counteracting apoptosis resistance in childhood leukaemia.
    Br J Haematol. 2009;145:441-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. LANASA MC , Allgood SD, Bond KM, Gockerman JP, et al
    Oligoclonal TRBV gene usage among CD8(+) T cells in monoclonal B lymphocytosis and CLL.
    Br J Haematol. 2009;145:535-7.
    PubMed     Text format     Related articles   
    
    
    
51. KEANE C , Henden A, Mills T, Wood P, et al
    Myeloid and lymphoid neoplasm with FGFR1 abnormality.
    Br J Haematol. 2009;145:440.
    PubMed     Text format     Related articles   
    
    
    April 2009
52. TAKESHITA A , Shinjo K, Yamakage N, Ono T, et al
    CMC-544 (inotuzumab ozogamicin) shows less effect on multidrug resistant cells: analyses in cell lines and cells from patients with B-cell chronic lymphocytic leukaemia and lymphoma.
    Br J Haematol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. STEVENS JM , Macdougall F, Jenner M, Oakervee H, et al
    Patterns of recruitment into acute myeloid leukaemia (AML) 15 and outcome for young patients with AML at a single referral centre.
    Br J Haematol. 2009;145:40-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. TAYLOR GM , Richards S, Wade R, Hussain A, et al
    Relationship between HLA-DP supertype and survival in childhood acute lymphoblastic leukaemia: evidence for selective loss of immunological control of residual disease?
    Br J Haematol. 2009;145:87-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. RIZ I , Hawley TS, Johnston H, Hawley RG, et al
    Role of TLX1 in T-cell acute lymphoblastic leukaemia pathogenesis.
    Br J Haematol. 2009;145:140-3.
    PubMed     Text format     Related articles   
    
    
    
56. WONG KF , Chow E, Siu LL, Wong WS, et al
    Acute promyelocytic leukaemia with cryptic PML-RARA fusion.
    Br J Haematol. 2009;145:2.
    PubMed     Text format     Related articles   
    
    
    
57. MASERATI E , Pressato B, Valli R, Minelli A, et al
    The route to development of myelodysplastic syndrome/acute myeloid leukaemia in Shwachman-Diamond syndrome: the role of ageing, karyotype instability, and acquired chromosome anomalies.
    Br J Haematol. 2009;145:190-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. TRIKALINOS NA , Soupir CP, Dey BR
    Lineage switch of acute lymphocyctic leukaemia with t(4;11)(q21;q23) into acute myeloid leukaemia in an adult patient after allogeneic stem cell transplantation.
    Br J Haematol. 2009;145:262-4.
    PubMed     Text format     Related articles   
    
    
    March 2009
59. JAIME-PEREZ JC , Rodriguez-Romo LN, Gonzalez-Llano O, Chapa-Rodriguez A, et al
    Effectiveness of intrathecal rituximab in patients with acute lymphoblastic leukaemia relapsed to the CNS and resistant to conventional therapy.
    Br J Haematol. 2009;144:794-5.
    PubMed     Text format     Related articles   
    
    
    
60. MASAMOTO Y , Nannya Y, Arai S, Koike Y, et al
    Evidence for basophilic differentiation of acute promyelocytic leukaemia cells during arsenic trioxide therapy.
    Br J Haematol. 2009;144:798-9.
    PubMed     Text format     Related articles   
    
    
    
61. MEKLAT F , Zhang Y, Shahriar M, Ahmed SU, et al
    Identification of protamine 1 as a novel cancer-testis antigen in early chronic lymphocytic leukaemia.
    Br J Haematol. 2009;144:660-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. DESMOND R , McDerra J, Kelly K, Smith O, et al
    Multiple vertebral collapse as a presentation of childhood acute lymphoblastic leukaemia.
    Br J Haematol. 2009;144:627.
    PubMed     Text format     Related articles   
    
    
    
63. GRIBBEN JG , Hallek M
    Rediscovering alemtuzumab: current and emerging therapeutic roles.
    Br J Haematol. 2009;144:818-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. LAPALOMBELLA R , Gowda A, Joshi T, Mehter N, et al
    The humanized CD40 antibody SGN-40 demonstrates pre-clinical activity that is enhanced by lenalidomide in chronic lymphocytic leukaemia.
    Br J Haematol. 2009;144:848-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. HEIDEL F , Lipka DB, Mirea FK, Mahboobi S, et al
    Bis(1H-indol-2-yl)methanones are effective inhibitors of FLT3-ITD tyrosine kinase and partially overcome resistance to PKC412A in vitro.
    Br J Haematol. 2009;144:865-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. JO A , Tsukimoto I, Ishii E, Asou N, et al
    Age-associated difference in gene expression of paediatric acute myelomonocytic lineage leukaemia (FAB M4 and M5 subtypes) and its correlation with prognosis.
    Br J Haematol. 2009;144:917-29.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. GIEBEL S , Krawczyk-Kulis M, Kyrcz-Krzemien S, Haus O, et al
    Could cytogenetics and minimal residual disease replace conventional risk criteria in adults with Ph-negative acute lymphoblastic leukaemia?
    Br J Haematol. 2009;144:970-2.
    PubMed     Text format     Related articles   
    
    
    
68. GAIKWAD A , Rye CL, Devidas M, Heerema NA, et al
    Prevalence and clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukaemia.
    Br J Haematol. 2009;144:930-2.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. PAULSSON K , An Q, Moorman AV, Parker H, et al
    Methylation of tumour suppressor gene promoters in the presence and absence of transcriptional silencing in high hyperdiploid acute lymphoblastic leukaemia.
    Br J Haematol. 2009;144:838-47.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
70. KANG MH , Harutyunyan N, Hall CP, Papa RA, et al
    Methotrexate and aminopterin exhibit similar in vitro and in vivo preclinical activity against acute lymphoblastic leukaemia and lymphoma.
    Br J Haematol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. PARK MJ , Taki T, Oda M, Watanabe T, et al
    FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma.
    Br J Haematol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. RICCI C , Onida F, Servida F, Radaelli F, et al
    In vitro anti-leukaemia activity of sphingosine kinase inhibitor.
    Br J Haematol. 2009;144:350-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. KHANIM FL , Bradbury CA, Arrazi J, Hayden RE, et al
    Elevated FOSB-expression; a potential marker of valproate sensitivity in AML.
    Br J Haematol. 2009;144:332-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. RICCIONI R , Diverio D, Riti V, Buffolino S, et al
    Interleukin (IL)-3/granulocyte macrophage-colony stimulating factor/IL-5 receptor alpha and beta chains are preferentially expressed in acute myeloid leukaemias with mutated FMS-related tyrosine kinase 3 receptor.
    Br J Haematol. 2009;144:376-87.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. ZEIDLER C , Germeshausen M, Klein C, Welte K, et al
    Clinical implications of ELA2-, HAX1-, and G-CSF-receptor (CSF3R) mutations in severe congenital neutropenia.
    Br J Haematol. 2009;144:459-67.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. BROOKE G , Rossetti T, Pelekanos R, Ilic N, et al
    Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials.
    Br J Haematol. 2009;144:571-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. REISMULLER B , Attarbaschi A, Peters C, Dworzak MN, et al
    Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria--a population-based report of the Austrian Berlin-Frankfurt-Munster (BFM) Study Group.
    Br J Haematol. 2009;144:559-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. PAPADAKI C , Dufour A, Seibl M, Schneider S, et al
    Monitoring minimal residual disease in acute myeloid leukaemia with NPM1 mutations by quantitative PCR: clonal evolution is a limiting factor.
    Br J Haematol. 2009;144:517-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. ROWE JM
    Optimal management of adults with ALL.
    Br J Haematol. 2009;144:468-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. CHEUNG AM , Chow HC, Liang R, Leung AY, et al
    A comparative study of bone marrow and peripheral blood CD34+ myeloblasts in acute myeloid leukaemia.
    Br J Haematol. 2009;144:484-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. KARRMAN K , Kjeldsen E, Lassen C, Isaksson M, et al
    The t(X;7)(q22;q34) in paediatric T-cell acute lymphoblastic leukaemia results in overexpression of the insulin receptor substrate 4 gene through illegitimate recombination with the T-cell receptor beta locus.
    Br J Haematol. 2009;144:546-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. BOMBEN R , Dal Bo M, Capello D, Forconi F, et al
    Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
    Br J Haematol. 2009;144:492-506.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. MUZIO M , Scielzo C, Bertilaccio MT, Frenquelli M, et al
    Expression and function of toll like receptors in chronic lymphocytic leukaemia cells.
    Br J Haematol. 2009;144:507-16.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. NOURSE J , Jones K, Gandhi MK
    The role of Epstein-Barr virus in Richter syndrome.
    Br J Haematol. 2009;144:613.
    PubMed     Text format     Related articles   
    
    
    January 2009
85. BOHMER FD , Uecker A
    A substrate peptide for the FLT3 receptor tyrosine kinase.
    Br J Haematol. 2009;144:127-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. MOTWANI J , Jesson J, Sturch E, Jones S, et al
    Predictive value of flow cytometric minimal residual disease analysis in childhood acute lymphoblastic leukaemia at the end of remission induction therapy: results from a single UK centre.
    Br J Haematol. 2009;144:133-5.
    PubMed     Text format     Related articles   
    
    
    
87. SCHARN N , Ballmaier M, Reinhardt K, Ehlers S, et al
    CSF3R mutations in paediatric acute myeloid leukaemia.
    Br J Haematol. 2009;144:140-2.
    PubMed     Text format     Related articles   
    
    
    
88. SCHWEIGHOFER CD , Ritgen M, Eichhorst BF, Busch R, et al
    Consolidation with alemtuzumab improves progression-free survival in patients with chronic lymphocytic leukaemia (CLL) in first remission: long-term follow-up of a randomized phase III trial of the German CLL Study Group (GCLLSG).
    Br J Haematol. 2009;144:95-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. KARLSSON C , Lundin J, Kimby E, Kennedy B, et al
    Phase II study of subcutaneous alemtuzumab without dose escalation in patients with advanced-stage, relapsed chronic lymphocytic leukaemia.
    Br J Haematol. 2009;144:78-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. HATFIELD K , Oyan AM, Ersvaer E, Kalland KH, et al
    Primary human acute myeloid leukaemia cells increase the proliferation of microvascular endothelial cells through the release of soluble mediators.
    Br J Haematol. 2009;144:53-68.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. RYAN J , Quinn F, Meunier A, Boublikova L, et al
    Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time-points reveals high levels of concordance between molecular and immunophenotypic approaches.
    Br J Haematol. 2009;144:107-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. BOUZAR AB , Boxus M, Defoiche J, Berchem G, et al
    Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells.
    Br J Haematol. 2009;144:41-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. GREEN L , Coumbe A, Sawicka E, De Lord C, et al
    Mycobacterium kansasii in a patient with hairy cell leukaemia.
    Br J Haematol. 2009;144:2.
    PubMed     Text format     Related articles   
    
    
    
94. DEAMBROGI C , Cresta S, Cerri M, Rasi S, et al
    14q32 Translocations and risk of Richter transformation in chronic lymphocytic leukaemia.
    Br J Haematol. 2009;144:131-3.
    PubMed     Text format     Related articles   
    
    
    
95. ALBANO F , Anelli L, Zagaria A, Liso V, et al
    MIRN199B downregulation in chronic myeloid leukaemia is associated with deletions on der(9).
    Br J Haematol. 2009;144:271-3.
    PubMed     Text format     Related articles   
    
    
    
96. NUCKEL H , Frey UH, Sellmann L, Collins CH, et al
    The IKZF3 (Aiolos) transcription factor is highly upregulated and inversely correlated with clinical progression in chronic lymphocytic leukaemia.
    Br J Haematol. 2009;144:268-70.
    PubMed     Text format     Related articles   
    
    
    
97. PRATT G , Harding S, Holder R, Fegan C, et al
    Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia.
    Br J Haematol. 2009;144:217-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. DALMAZZO LF , Jacomo RH, Marinato AF, Figueiredo-Pontes LL, et al
    The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment.
    Br J Haematol. 2009;144:223-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. MOHAMEDALI A , Guinn BA, Sahu S, Thomas NS, et al
    Serum profiling reveals distinctive proteomic markers in chronic myeloid leukaemia patients.
    Br J Haematol. 2009;144:263-5.
    PubMed     Text format     Related articles   
    
    
    
100. HARRISON CJ
     Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia.
     Br J Haematol. 2009;144:147-56.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2008
101. AMREIN L , Hernandez TA, Ferrario C, Johnston J, et al
     Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabine in vitro.
     Br J Haematol. 2008;143:698-706.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. NAHI H , Jansson M, Sander B, Ljungman P, et al
     Transmission of chronic lymphocytic leukaemia from a blood stem cell sibling donor to the recipient.
     Br J Haematol. 2008;143:751-3.
     PubMed     Text format     Related articles   
     
     
     
103. CHEVALLIER P , Robillard N, Ayari S, Guillaume T, et al
     Persistence of CD33 expression at relapse in CD33(+) acute myeloid leukaemia patients after receiving Gemtuzumab in the course of the disease.
     Br J Haematol. 2008;143:744-6.
     PubMed     Text format     Related articles   
     
     
     
104. JENKINS C , Hewamana S, Gilkes A, Neelakantan S, et al
     Nuclear factor-kappaB as a potential therapeutic target for the novel cytotoxic agent LC-1 in acute myeloid leukaemia.
     Br J Haematol. 2008;143:661-71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. LI WW , Hutnik M, Gehr G
     Antiangiogenesis in haematological malignancies.
     Br J Haematol. 2008;143:622-31.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. ELSE M , Smith AG, Cocks K, Richards SM, et al
     Patients' experience of chronic lymphocytic leukaemia: baseline health-related quality of life results from the LRF CLL4 trial.
     Br J Haematol. 2008;143:690-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. LATAGLIATA R , Breccia M, Fazi P, Iacobelli S, et al
     Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia.
     Br J Haematol. 2008;143:681-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. SOVINZ P , Lackner H, Urban C
     Recurrent episodes of fever and pancytopenia due to haemophagocytosis during maintenance therapy for acute myeloid leukaemia.
     Br J Haematol. 2008;143:605.
     PubMed     Text format     Related articles   
     
     
     November 2008
109. BHATLA D , Gerbing RB, Alonzo TA, Conner H, et al
     Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia.
     Br J Haematol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. AU WY , Ha SY, Chow EY, Wan TS, et al
     A unique case of familial leukaemia: maternal puerperal leukaemia followed by infantile leukaemia with monosomy 7.
     Br J Haematol. 2008;143:445-6.
     PubMed     Text format     Related articles   
     
     
     
111. ROTH A , de Beer D, Nuckel H, Sellmann L, et al
     Significantly shorter telomeres in T-cells of patients with ZAP-70+/CD38+ chronic lymphocytic leukaemia.
     Br J Haematol. 2008;143:383-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. BROWN JR , Neuberg D, Phillips K, Reynolds H, et al
     Prevalence of familial malignancy in a prospectively screened cohort of patients with lymphoproliferative disorders.
     Br J Haematol. 2008;143:361-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. ZHURAVLEVA J , Paggetti J, Martin L, Hammann A, et al
     MOZ/TIF2-induced acute myeloid leukaemia in transgenic fish.
     Br J Haematol. 2008;143:378-82.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. YANADA M , Sugiura I, Takeuchi J, Akiyama H, et al
     Prospective monitoring of BCR-ABL1 transcript levels in patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia undergoing imatinib-combined chemotherapy.
     Br J Haematol. 2008;143:503-10.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. BRETHON B , Yakouben K, Oudot C, Boutard P, et al
     Efficacy of fractionated gemtuzumab ozogamicin combined with cytarabine in advanced childhood myeloid leukaemia.
     Br J Haematol. 2008;143:541-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
116. FORCONI F , Rinaldi A, Kwee I, Sozzi E, et al
     Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion.
     Br J Haematol. 2008;143:532-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. CAMPANA D
     Status of minimal residual disease testing in childhood haematological malignancies.
     Br J Haematol. 2008;143:481-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     October 2008
118. CHTIOUI H , Millius C, Lammle B, Lauterburg BH, et al
     Concomitant treatment with lamivudine renders cladribine inactive by inhibition of its phosphorylation.
     Br J Haematol. 2008.
     PubMed     Text format     Related articles   
     
     
     
119. BENTHAUS T , Schneider F, Mellert G, Zellmeier E, et al
     Rapid and sensitive screening for CEBPA mutations in acute myeloid leukaemia.
     Br J Haematol. 2008;143:230-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
120. DEFOICHE J , Debacq C, Asquith B, Zhang Y, et al
     Reduction of B cell turnover in chronic lymphocytic leukaemia.
     Br J Haematol. 2008;143:240-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
121. CERVETTI G , Galimberti S, Andreazzoli F, Fazzi R, et al
     Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow-up.
     Br J Haematol. 2008;143:296-8.
     PubMed     Text format     Related articles   
     
     
     
122. MUIRHEAD CR
     Chronic lymphocytic leukaemia: an overview of aetiology--comment.
     Br J Haematol. 2008;143:295-6.
     PubMed     Text format     Related articles   
     
     
     
123. SILBERSTEIN L , Johnston C, Bhagat A, Tibi L, et al
     Pituitary apoplexy during induction chemotherapy for acute myeloid leukaemia.
     Br J Haematol. 2008;143:151.
     PubMed     Text format     Related articles   
     
     
     
124. VAN VLIERBERGHE P , Pieters R, Beverloo HB, Meijerink JP, et al
     Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia.
     Br J Haematol. 2008;143:153-68.
     PubMed     Text format     Related articles    Abstract available
     
     
     September 2008
125. CAZIN B , Divine M, Lepretre S, Travade P, et al
     High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemia.
     Br J Haematol. 2008;143:54-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. BEESLEY AH , Weller RE, Kees UR
     The role of BSG (CD147) in acute lymphoblastic leukaemia and relapse.
     Br J Haematol. 2008;142:1000-2.
     PubMed     Text format     Related articles   
     
     
     
127. SUTTON L , Chaoui D, Cazin B, Azar N, et al
     Autologous activated macrophages (MAK) coated ex vivo with humanized anti-CD20 monoclonal antibodies can eradicate minimal residual disease in chronic lymphocytic leukaemia in clinical response.
     Br J Haematol. 2008;142:996-8.
     PubMed     Text format     Related articles   
     
     
     
128. ROOS C , Stenke L, Ohm L, Widell S, et al
     Clinical imatinib mesylate treatment induces early normalisation of aberrant neutrophil leukotriene C4 synthase expression and activity in chronic myeloid leukaemia.
     Br J Haematol. 2008;142:992-5.
     PubMed     Text format     Related articles   
     
     
     
129. PACKHAM G
     The role of NF-kappaB in lymphoid malignancies.
     Br J Haematol. 2008;143:3-15.
     PubMed     Text format     Related articles    Abstract available
     
     
     
130. BARRETT AJ
     Understanding and harnessing the graft-versus-leukaemia effect.
     Br J Haematol. 2008;142:877-88.
     PubMed     Text format     Related articles    Abstract available
     
     
     
131. COLL-MULET L , Santidrian AF, Cosialls AM, Iglesias-Serret D, et al
     Multiplex ligation-dependent probe amplification for detection of genomic alterations in chronic lymphocytic leukaemia.
     Br J Haematol. 2008;142:793-801.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. LO KC , Chalker J, Strehl S, Neat M, et al
     Array comparative genome hybridization analysis of acute lymphoblastic leukaemia and acute megakaryoblastic leukaemia in patients with Down syndrome.
     Br J Haematol. 2008;142:934-45.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. JOST E , Schmid J, Wilop S, Schubert C, et al
     Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia.
     Br J Haematol. 2008;142:745-53.
     PubMed     Text format     Related articles    Abstract available
     
     
     
134. CASCAVILLA N , D'Arena G, Greco MM, Melillo L, et al
     Gemtuzumab ozogamicin as maintenance therapy after autologous stem cell transplantation in elderly patients with acute myeloid leukaemia.
     Br J Haematol. 2008;142:852-3.
     PubMed     Text format     Related articles   
     
     
     
135. OMOTI CE , Omoti AE
     Richter syndrome: a review of clinical, ocular, neurological and other manifestations.
     Br J Haematol. 2008;142:709-16.
     PubMed     Text format     Related articles    Abstract available
     
     
     
136. GRIER DD , Al-Quran SZ, Gray B, Li Y, et al
     Intracranial myeloid sarcoma.
     Br J Haematol. 2008;142:681.
     PubMed     Text format     Related articles   
     
     
     August 2008
137. ABROMOWITCH M , Sposto R, Perkins S, Zwick D, et al
     Shortened intensified multi-agent chemotherapy and non-cross resistant maintenance therapy for advanced lymphoblastic lymphoma in children and adolescents: report from the Children's Oncology Group.
     Br J Haematol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
138. ISHITSUKA K , Ikeda S, Utsunomiya A, Saburi Y, et al
     Smouldering adult T-cell leukaemia/lymphoma: a follow-up study in Kyushu.
     Br J Haematol. 2008.
     PubMed     Text format     Related articles   
     
     
     
139. CAVAZZINI F , Hernandez JA, Gozzetti A, Russo Rossi A, et al
     Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis.
     Br J Haematol. 2008;142:529-37.
     PubMed     Text format     Related articles    Abstract available
     
     
     
140. LANE SW , Fairbairn DJ, McCarthy C, Nandini A, et al
     Leukaemia cutis in atypical chronic myeloid leukaemia with a t(9;22) (p24;q11.2) leading to BCR-JAK2 fusion.
     Br J Haematol. 2008;142:503.
     PubMed     Text format     Related articles   
     
     
     
141. JOSE-ENERIZ ES , Roman-Gomez J, Cordeu L, Ballestar E, et al
     BCR-ABL1-induced expression of HSPA8 promotes cell survival in chronic myeloid leukaemia.
     Br J Haematol. 2008;142:571-82.
     PubMed     Text format     Related articles    Abstract available
     
     
     
142. MURAMATSU H , Kato K, Watanabe N, Matsumoto K, et al
     Risk factors for early death in neonates with Down syndrome and transient leukaemia.
     Br J Haematol. 2008;142:610-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
143. GUNAWARDANA C , Austen B, Powell JE, Fegan C, et al
     South Asian chronic lymphocytic leukaemia patients have more rapid disease progression in comparison to White patients.
     Br J Haematol. 2008;142:606-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
144. LIN TT , Hewamana S, Ward R, Taylor H, et al
     Highly purified CD38 sub-populations show no evidence of preferential clonal evolution despite having increased proliferative activity when compared with CD38 sub-populations derived from the same chronic lymphocytic leukaemia patient.
     Br J Haematol. 2008;142:595-605.
     PubMed     Text format     Related articles    Abstract available
     
     
     
145. CRAIG J , Walker K, Sales M, Cunningham J, et al
     Sequential tyrosine kinase inhibitor therapy: sustained disease remission in Philadelphia-positive erythroleukaemia.
     Br J Haematol. 2008;142:674-5.
     PubMed     Text format     Related articles   
     
     
     July 2008
146. GREY M
     Efficacy of alemtuzumab in cutaneous chronic lymphocytic leukaemia involving facial skin.
     Br J Haematol. 2008;142:1.
     PubMed     Text format     Related articles   
     
     
     
147. HUH YO , Lin KI, Vega F, Schlette E, et al
     MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis.
     Br J Haematol. 2008;142:36-44.
     PubMed     Text format     Related articles    Abstract available
     
     
     
148. DORES GM , Matsuno RK, Weisenburger DD, Rosenberg PS, et al
     Hairy cell leukaemia: a heterogeneous disease?
     Br J Haematol. 2008;142:45-51.
     PubMed     Text format     Related articles    Abstract available
     
     
     
149. OTTEN J , Schultze A, Schafhausen P, Otterstetter S, et al
     Blood outgrowth endothelial cells from chronic myeloid leukaemia patients are BCR/ABL1 negative.
     Br J Haematol. 2008;142:115-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
150. BARBARROJA N , Siendones E, Torres LA, Luque MJ, et al
     MEK inhibition induces caspases activation, differentiation blockade and PML/RARalpha degradation in acute promyelocytic leukaemia.
     Br J Haematol. 2008;142:27-35.
     PubMed     Text format     Related articles    Abstract available
     
     
     
151. MACLEOD RA , Drexler HG
     Leukaemia cell lines are robust in vitro models.
     Br J Haematol. 2008;142:137-8.
     PubMed     Text format     Related articles   
     
     
     
152. LUCENA-ARAUJO AR , Panepucci RA, dos Santos GA, Jacomo RH, et al
     The expression of DeltaNTP73, TATP73 and TP53 genes in acute myeloid leukaemia is associated with recurrent cytogenetic abnormalities and in vitro susceptibility to cytarabine cytotoxicity.
     Br J Haematol. 2008;142:74-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     June 2008
153. GUERIN E , Mahon FX, Lippert E
     Bundles of Auer rods in blast cells and mature neutrophils in a non-promyelocytic acute myeloblastic leukaemia.
     Br J Haematol. 2008;141:749.
     PubMed     Text format     Related articles   
     
     
     
154. ROBINSON BW , Behling KC, Gupta M, Zhang AY, et al
     Abundant anti-apoptotic BCL-2 is a molecular target in leukaemias with t(4;11) translocation.
     Br J Haematol. 2008;141:827-39.
     PubMed     Text format     Related articles    Abstract available
     
     
     
155. OVERES IM , de Rijke B, van Horssen-Zoetbrood A, Fredrix H, et al
     Expression of P2X5 in lymphoid malignancies results in LRH-1-specific cytotoxic T-cell-mediated lysis.
     Br J Haematol. 2008;141:799-807.
     PubMed     Text format     Related articles    Abstract available
     
     
     
156. OMMEN HB , Nyvold CG, Braendstrup K, Andersen BL, et al
     Relapse prediction in acute myeloid leukaemia patients in complete remission using WT1 as a molecular marker: development of a mathematical model to predict time from molecular to clinical relapse and define optimal sampling intervals.
     Br J Haematol. 2008;141:782-91.
     PubMed     Text format     Related articles    Abstract available
     
     
     
157. CHU M , Siegmund KD, Hao QL, Crooks GM, et al
     Inferring relative numbers of human leucocyte genome replications.
     Br J Haematol. 2008;141:862-71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
158. MANCINI M , Zuffa E, Veljkovic N, Brusa G, et al
     IPO-trimethylation of histone H3-lysine9 associated with P210 BCR-ABL tyrosine kinase of chronic myeloid leukaemia.
     Br J Haematol. 2008;141:899-902.
     PubMed     Text format     Related articles   
     
     
     
159. NGO NT , Lampert IA, Naresh KN
     Bone marrow trephine morphology and immunohistochemical findings in chronic myelomonocytic leukaemia.
     Br J Haematol. 2008;141:771-81.
     PubMed     Text format     Related articles    Abstract available
     
     
     May 2008
160. LIAPIS K , Bakiri M, Apostolidis J
     Erythroblastic synartesis in a patient with small lymphocytic lymphoma.
     Br J Haematol. 2008;.
     PubMed     Text format     Related articles   
     
     
     
161. KOIKE K , Matsuda K
     Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia.
     Br J Haematol. 2008;141:567-75.
     PubMed     Text format     Related articles    Abstract available
     
     
     
162. BRAUN T , Fenaux P
     Farnesyltransferase inhibitors and their potential role in therapy for myelodysplastic syndromes and acute myeloid leukaemia.
     Br J Haematol. 2008;141:576-86.
     PubMed     Text format     Related articles    Abstract available
     
     
     
163. ZENZ T , Dohner K, Denzel T, Dohner H, et al
     Chronic lymphocytic leukaemia and acute myeloid leukaemia are not associated with AKT1 pleckstrin homology domain (E17K) mutations.
     Br J Haematol. 2008;141:742-3.
     PubMed     Text format     Related articles   
     
     
     
164. ROSSI D , De Paoli L, Rossi FM, Cerri M, et al
     Early stage chronic lymphocytic leukaemia carrying unmutated IGHV genes is at risk of recurrent infections during watch and wait.
     Br J Haematol. 2008;141:734-6.
     PubMed     Text format     Related articles   
     
     
     
165. SATO T , Toki T, Kanezaki R, Xu G, et al
     Functional analysis of JAK3 mutations in transient myeloproliferative disorder and acute megakaryoblastic leukaemia accompanying Down syndrome.
     Br J Haematol. 2008;141:681-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
166. LEE CY , Tien HF, Hou HA, Chou WC, et al
     Marrow osteopontin level as a prognostic factor in acute myeloid leukaemia.
     Br J Haematol. 2008;141:736-9.
     PubMed     Text format     Related articles   
     
     
     
167. FORCONI F , Poretti G, Kwee I, Sozzi E, et al
     High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia.
     Br J Haematol. 2008;141:622-30.
     PubMed     Text format     Related articles    Abstract available
     
     
     
168. PALMER S , Hanson CA, Zent CS, Porrata LF, et al
     Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia.
     Br J Haematol. 2008;141:607-14.
     PubMed     Text format     Related articles    Abstract available
     
     
     
169. MOHAMEDBHAI S , Pule M, Conn B, Hopper C, et al
     Acute promyelocytic leukaemia presenting with a myeloid sarcoma of the tongue.
     Br J Haematol. 2008;141:565.
     PubMed     Text format     Related articles   
     
     
     
170. DOYEN J , Italiano A, Peyrade F, Bouyer C, et al
     Gemtuzumab ozogamicin plus cytarabine in elderly patients with relapsed or refractory acute myeloid leukaemia.
     Br J Haematol. 2008;141:744-5.
     PubMed     Text format     Related articles   
     
     
     
171. DE LAVALLADE H , Punnialingam S, Milojkovic D, Bua M, et al
     Pleural effusions in patients with chronic myeloid leukaemia treated with dasatinib may have an immune-mediated pathogenesis.
     Br J Haematol. 2008;141:745-7.
     PubMed     Text format     Related articles   
     
     
     March 2008
172. ZENT CS , Ding W, Schwager SM, Reinalda MS, et al
     The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma.
     Br J Haematol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: